Who
Amol Chaubal
SVP & Chief Financial Officer
Company insider
Files Form 4 as: SVP & Chief Financial Officer, Waters; Chief Financial Officer, Quanterix.
In numbers
- Trades disclosed
- 59
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $175K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 12 Apr 2019
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | WAT WatersLife-science tools | SEC FORM 4 Code F | $84K239 at $352.21 | filing |
| 12 May 2026filed 14 May 2026 | WAT WatersLife-science tools | SEC FORM 4 Code F | $84K239 at $352.21 | filing |
| 2 Mar 2026filed 3 Mar 2026 | WAT WatersLife-science tools | SEC FORM 4 Code F | $218K709 at $307.23 | filing |
| 2 Mar 2026filed 3 Mar 2026 | WAT WatersLife-science tools | SEC FORM 4 Code F | $218K709 at $307.23 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —1,455 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,125 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,125 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —1,455 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code F | $22K58 at $376.89 | filing |
| 5 Feb 2026filed 6 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code F | $22K58 at $376.89 | filing |
| 4 Feb 2026filed 6 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —1,884 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —1,884 at $0.00 | filing |
| 12 May 2025filed 14 May 2025 | WAT WatersLife-science tools | SEC FORM 4 Code F | $88K239 at $366.67 | filing |
| 1 Mar 2025filed 4 Mar 2025 | WAT WatersLife-science tools | SEC FORM 4 Code F | $400K1,076 at $371.79 | filing |
| 5 Feb 2025filed 7 Feb 2025 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,287 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | WAT WatersLife-science tools | SEC FORM 4 Code A | —3,317 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | WAT WatersLife-science tools | SEC FORM 4 Code A | —833 at $0.00 | filing |
| 13 May 2024filed 14 May 2024 | WAT WatersLife-science tools | SEC FORM 4 Code F | $51K145 at $349.28 | filing |
| 7 Feb 2024filed 9 Feb 2024 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —8,228 at $0.00 | filing |
| 12 May 2023filed 15 May 2023 | WAT WatersLife-science tools | SEC FORM 4 Code F | $39K145 at $271.00 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisQTRX · tickerreport.com · 15 Oct 2026ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker ResearchQTRX · prnewswire.com · 8 Oct 2026
0 headlines in the last 90 days name Amol Chaubal; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.